Last updated on July 2018

BGB 3111 in Combination With Obinutuzumab in Subjects With B-Cell Lymphoid Malignancies


Brief description of study

This study is evaluating the safety and preliminary efficacy of BGB-3111 in combination with obinutuzumab in subjects with B-cell lymphoid malignancies.

Clinical Study Identifier: NCT02569476

Contact Investigators or Research Sites near you

Start Over

William Novonty, MD

The Alfred Hospital
Melbourne, Australia
1.05miles

William Novonty, MD

St Frances Xavier Cabrini Hospital
Malvern, Australia
2.99miles

William Novonty, MD

St Vincent's Hospital Melbourne
East Melbourne, Australia
3.31miles